SFL will host a joint webinar with Swiss Medtech on combined products on 11 May 2021
Registrations are now open for the SFL and Swiss Medtech joint 1-hour free webinar on ‘Combined products in EU and CH: regulatory framework, challenges & opportunities’, taking place on 11 May 2021, 12:00-13:00 CEST.
The webinar will provide participants with an overview of the framework for products combining medicinal product and medical device components in the EU and in Switzerland.
It will be presented by experts in the pharma and medtech fields: Shayesteh Fürst-Ladani, SFL’s CEO, Daniel Delfosse, Executive Board Member and Regulatory Affairs Director at Swiss Medtech, and Mike Wallenstein, Global Head MDR Implementation & DD&C Compliance at Novartis.
SFL’s experienced medical devices and combined products team can support you with all aspects of MDR/IVDR implementation for medical devices (including software), combined products and in vitro diagnostics (including companion diagnostics, genetic tests, and near-patient testing devices).